Nasser Hanna, MD

Medical Oncologist

Conditions Treated

Lung Cancer Testicular Mesothelioma

Bio & Insurance Information

Dr. Nasser Hanna is a medical oncologist who lives in Indianapolis, Indiana and works with several hospitals including Richard L Roudebush VA Medical Center. He got his medical degree from University of Missouri and did an internship and a residency at University of Iowa. He completed his medical studies with a fellowship at Indiana University Health Methodist Hospital. Dr. Nasser Hanna is board certified in oncology and has over 20 years of experience.



Education & Training

University Of Missouri--Columbia School Of Medicine Graduated in 1995

Medical School

University Iowa Completed in 1996

Internship

University Iowa Completed in 1998

Residency

Indiana University Health Methodist Hospital

Fellowship

Board Certifications

American Board of Internal Medicine - Oncology

Hospitals & Clinics

Eskenazi Health

Languages: English/Spanish

(317) 880-0000

720 Eskenazi Ave

Indianapolis, Indiana 46202

Read More

IU Health University Hospital

Languages: English/Spanish

(317) 944-5000

550 University Blvd

Indianapolis, Indiana 46202

Read More

Richard L Roudebush VA Medical Center

Languages: English/Spanish

(317) 554-0000

1481 W 10th St

Indianapolis, Indiana 46202

Read More

Publications

Dr. Nasser Hanna has contributed to 3 publications.

Prognostic factors in patients with poor risk germ cell tumors: a retrospective analysis of the Indiana University experience from 1990-2014.

Adra, N.,Althouse, S. K.,Liu, H.,Brames, M. J.,Hanna, N. H.,Einhorn, L. H.,Albany, C.; Ann. Oncol.. 2016 Feb 11.

See more >>

Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier C.

Adra, N.,Albany, C.,Brames, M. J.,Case-Eads, S.,Johnson, C. S.,Liu, Z.,Fausel, C. A.,Breen, T.,Hanna, N. H.,Hauke, R. J.,Picus, J.,Einhorn, L. H.; Support Care Cancer. 2016 Feb 04.

See more >>

Electronic nicotine delivery systems: a policy statement from the american association for cancer research and the american society of clinical oncology.

Brandon, T. H.,Goniewicz, M. L.,Hanna, N. H.,Hatsukami, D. K.,Herbst, R. S.,Hobin, J. A.,Ostroff, J. S.,Shields, P. G.,Toll, B. A.,Tyne, C. A.,Viswanath, K.,Warren, G. W.; J. Clin. Oncol.. 2015 Jan 13.

See more >>

Memberships

American Society of Clinical Oncology